management of pulmonary embolism in emergency department
DESCRIPTION
An short overview of the diagnostic approach and treatment options for Pulmonary Embolism which is a Medical Emergency. In the USA alone about 600,000 people are diagnosed with Pulmonary Embolism every year. However, this is just the tip of the iceberg as many more people have sudden head due to this notorious condition. This Power Point presentation will give you some idea based on my experience in the Emergency Departments in 3 continents of the world.TRANSCRIPT
Management of Pulmonary Embolism in Emergency Department
Dr A. BaraiMBBS, MRCS Ed, MSc
Registrar in Emergency Medicine
Topics• Introduction
• Diagnostic approach
• Treatment options
• Special circumstances: Pregnant patient
• Prevention
Introduction• Pulmonary embolism (PE) is a medical emergency
where pulmonary artery or its branches are blocked with embolic substances most commonly blood clots
• Most cases are not life threatening.
• Incidence: 600,000/year in USA
• Mortality rate: 50,000 to 200,000/yr in US
Types of PE• Massive PE: Acute PE with obstructive shock or SBP
<90 mmHg
• Sub-massive PE: Acute PE without systemic hypotension (SBP ≥90 mm Hg) but with either RV dysfunction or myocardial necrosis
• Non-massive or low risk PE: None of the above severe features.
Pathophysiology
Deep vein thrombosis from large vein commonly above the knee → Inferior vena cava → Right atrium → Right ventricle → Pulmonary artery → PE
Ventilation perfusion mismatch → Hypoxemia
↓Venous return → Right heart failure → Shock
Diagnosis• Risk stratification
• Clinical examination
• Bed side tests
• Laboratory tests
• Imaging techniques
Risk factors• Alteration of blood flow:
– Prolonged immobilisation, – Obesity, – Pregnancy, – Cancer
• Factors in blood vessel wall: – Surgery, – Catheterisation.– Trauma
• Hypercoagulable states: – Estrogen containing OCP, – Genetic thrombophilia (Factor V Leiden deficiency, Protein C and
Protein S deficiency, antithrombin deficiency etc.), – Acquired thrombophilia (antiphospholipid syndrome, nephrotic
syndrome, paroxysmal nocturnal hemoglobinuria)
Risk stratification• Clinical judgement
• Wells score for PE
• Modified Geneva score for PE
Wells score for PE
Modified Geneva score for PE
Clinical Presentation: Symptoms• Chest pain: Sharp, pleuritic in nature, no radiation,
aggravated by coughing and deep breath
• Haemoptysis
• Shortness of breath
• Collapse
• Palpitations
• Sudden death: 15% of sudden death due to PE
Clinical Presentation: Signs• Dyspnoea, cyanosis, pale
• Tachypnea
• Tachycardia
• Hypoxia
• Hypotension
• Pulmonary hypertension
Chest examination• May be normal
• Friction rub
• Features of pleural effusion
• Raised JVP
Investigations• Bed side tests: ECG, ABG
• Blood tests: D-dimer, FBC, Troponin, UEC
• Imaging techniques: Ultrasound/ Doppler scan, Chest xray, CTPA, V/Q scan, Echocardiogram
ABG findings in PE
• pH= ↑ • PaO2= ↓• PaCO2= ↓• HCO3= Normal• Aa gradient= Large
Aa gradient= PAO2- PaO2
Chest xray• Mostly normal findings
• Done to exclude other pathology
• Plural effusion
• Specific signs:- Hampton’s hump- Westermark sign
Hampton’s hump
Westermark sign
ECG findings in PE• Normal sinus rhythm
• Sinus tachycardia
• Tall peaked T waves in V1- V4
• S1Q3T3 pattern: Not specific. Can be seen in any Cor pulmonale syndrome
• RBBB
S1Q3T3 pattern ECG
D-dimer in PE• D-dimer is a type of Fibrin degradation product
• Can be raised due to a number of reasons
• Negative D-dimer rules out PE/DVT in 98% cases
• False positive D-dimer: infection, pregnancy, renal failure, post-operative
Echocardiogram in PE
CTPAIndications:
- Suspected PE
Contra-indications:- Renal failure- Pregnancy- Allergy to radio-contrast
Procedure:- Radioactive iodine administered IV- CT scan performed
Ventilation-perfusion scanIndications:
- Renal failure- Pregnancy
Procedure:- Ventilation scan with Xenon inhalation- Perfusion scan with Tc99m labelled radioactive dye infusion- Scan V/Q- Result: unmatched V/Q
Pulmonary angiogram• Gold standard test for PE
• Not practised due to the side effects and high mortality
• Procedure:– Catheter inserted to right ventricle– Radio opaque dye injected– Imaging technique used to identify the clot
Treatment options• Symptomatic treatment:
– ABCD approach– Oxygen– Analgesia
• Anticoagulation:– IV Heparin– S/C LMWH eg Enoxaparine, Dalteparine– Oral Warfarin
• IVC filter: If there is contra-indications for anti-coagulation
• Thrombolysis: tPA eg Alteplase, Tenectaplase
• Surgical procedures: Pulmonary embolectomy
Treatment options
• Massive PE: Thrombolysis/embolectomy
• Sub-massive PE: Strongly consider thrombolysis/embolectomy but need to balance risk of bleeding
• Non-massive PE: Anticoagulation
Thrombolysis• Indications:
– Massive PE– Sub-massive PE where risk of bleeding low
• Contraindications:– Bleeding, recent stroke, HI, current GI bleeding, bleeding
PUD, surgery within 7 day, prolonged CPR
• Drugs:– Alteplase 100mg IV: 15mg IV stat followed by 85mg over
2 hours– Followed by Heparin infusion
Anticoagulation• IV Heparin:
– 80 units/kg bolus followed by – 18 units/kg infusion
• Monitor APTT 60-90 sec
• Side effects: – HITS (Heparin induced thrombocytopenia syndrome):
paradoxical hypercoagulable state leads to clots– Bleeding
AnticoagulationLow molecular weight Heparin (LMWH)
Enoxaprin (Clexane): S/C- 1.5mg/kg/24 hours Or 1mg/kg/12 hours- 1 mg/kg/24 hours in renal impairment
Duration: 6 to 9 months
Side effect: Low HITS
Anticoagulation• Vitamin K antagonist
• Warfarin: – 5mg PO initial dose– Check regular INR 2-3
• Side effects:– Bleeding– Unusual bruises– Headache
IVC filter
Indications:- DVT with massive pulmonary embolus- Recurrent PE not treatable with anticoagulation- Absolute contra-indications for anti-coagulation- Trauma patients
PE in Pregnancy• All three components of Virchow’s triad are affected during
pregnancy
• D-dimer has high negative predictive value. False positive result is common
• V/Q scan is preferred technique
• CTPA can be done if VQ is inconclusive
• Preferred treatment option: LMWH
• Warfarin is contraindicated
Prevention of PE• Control of obesity
• Stop smoking
• Stockings
• Heparin: 5000 units/day IV
• Enoxaprin: 40 mg/day S/C
And finally…
PE is often over-diagnosed;
PE is often under-diagnosed;
The over- or under-diagnosis of PE results in increased cost, morbidity, mortality and medico-legal risks.
References• Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010 Jul 15;363(3):266-74. doi:
10.1056/NEJMra0907731. Epub 2010 Jun 30
• Bourjeily G, Paidas M, Khalil H, et al. Pulmonary embolism in pregnancy.Lancet. 2010;375:500-512
• Hofman, M. S.; Beauregard, J. -M.; Barber, T. W. et al.(2011). 68Ga PET/CT Ventilation-Perfusion Imaging for Pulmonary Embolism: A Pilot Study with Comparison to Conventional Scintigraphy. Journal of Nuclear Medicine 52 (10): 1513–1519.
• Jaff MR, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011 Apr 26;123(16):1788-830. doi: 10.1161/CIR.0b013e318214914f. Epub 2011 Mar 21. Erratum in: Circulation. 2012 Mar 20;125(11):e495. Circulation. 2012 Aug 14;126(7):e104.
• Mattu, A. PE in pregnancy: A complicated diagnosis. Medscape. August 9, 2010 (Online) URL: http://www.medscape.com/viewarticle/726318
• Pulmonary embolism. Life in the fast lane. (Online). http://lifeinthefastlane.com/education/ccc/pulmonary-embolism/
Thank you!